臨床試驗

Stratagen Quantitative Prostate MRI Platform Pilot Study

NCT：NCT06985238 · ACTIVE_NOT_RECRUITING

NCT IDNCT06985238

狀態ACTIVE_NOT_RECRUITING

開始日期2025-09-24

完成時間2027-05-30

SponsorStratagen Bio, Inc. (INDUSTRY)

First posted2025-05-22

Last updated2026-10-09

簡要摘要

The goal of this clinical trial is to assess the safety and feasibility of the Stratagen Quantitative Prostate MRI Platform when used in addition to the standard scans conducted during the existing prostate MRI sessions. * What severe problems, if any, occur because of the use of the Stratagen Quantitative Prostate MRI Platform? * Can the data collected be used to measure quantitative MRI parameters? Participants will: \- Receive up to 15 minutes of additional MRI scan time during the existing prostate MRI imaging session.

官方來源

在 ClinicalTrials.gov 上查看 →

資料來自 ClinicalTrials.gov API。最新狀態請參閱官方紀錄。